Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Post by Howe9on Feb 27, 2019 6:32pm

199 Views

Post# 29420457

Conference call

Listened to today’s call, key points:
Functional device done by 3rd quarter 2019
FDA process start right after that, complete sometime in the 12 months following
Sometime in 2020 device ready for sale.
More money will be needed sometime before then.

This is will be bought out in 2020 IMO, reading between Jim H’s lines.

H9

Bullboard Posts

Visionstate set to leverage success in the U.S. market